Home/ Supplements/ Omega 3/ Omega-3 2400 mg

Omega-3 2400 mg

product on market Softgel Capsule Gaspari Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 38% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed ingredients consist of basic macronutrients, which provide foundational energy and structural support for the body. There is strong evidence that dietary fats and proteins are essential for overall health and cellular function. However, the specific evidence coverage for this formulation is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega-3 2400 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
38%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
35 Calorie(s)
Total Fat
3 Gram(s) (5% DV)
Cholesterol
25 mg (8% DV)
Carbohydrates
1 Gram(s) (1% DV)
Protein
1 Gram(s)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Glycerin Water Methacrylic Acid Copolymer Tocopherols
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

With meals Pre During Post Between meals

Suggested Use: As a dietary supplement, take 1 softgel two times daily with meal or as directed by the practitioner.

Warnings & Precautions

Warning: Cancer and reproductive harm www.P65Warnings.ca.gov

Contains: Fish (anchovy, sardine & marckerel)

Warning: This product is only intended to be consumed by healthy individuals over the age of 18 years.

If you are pregnant or nursing, taking any medication or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of the reach of children.

Tamper Evident: Do not use if seal under cap is broken or missing.

Formulation Notes

The Gaspari Difference Enteric coating increases bioavailability and limits gastric distress Highest concentration of DHA and EPA (70%) from 2,400 mg of fish oil 960 mg EPA and 720 mg DHA per serving

Gaspari's Omega 3 is made with enteric coated softgels, devised to pass through the stomach unaffected and dissolve in the intestinal tract. This ensures that the effacy of the formula is fully realized, and that the benefits of the product are achieved.

Made in the USA from domestic and international ingredients.

High strength enteric coated fish oil Omega-3 2400mg 40/30 EPA/DHA

Additional Information

OMEGA-3 is manufactured in Opa Locka, FL 33054 USA & is developed exclusively for Gaspri Nutrition

Store in a cool, dry place.

(30 servings)

Metadata

Product Details

UPC / SKU6 46511 02772 5
DSLD Entry Date2020-06-24
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID223186
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.